WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors
Yuji Sakuma(Sapporo Medical University), Yohei Miyagi(Kanagawa Prefectural Hospital Organization)
Cited by 47
Related Papers
Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia
|International Journal of Molecular Sciences|2016|208
Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis
|Laboratory Investigation|2016|74
Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas
|International Journal of Oncology|2018|21
Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component
|Translational Lung Cancer Research|2021|14
A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells
|International Journal of Molecular Sciences|2024|4